U.S. Minor Cannabinoids Market Revenue Analysis by Regions 2028
U.S. Minor Cannabinoids Industry Overview The U.S. minor cannabinoids market size is expected to reach USD 26.2 billion by 2028, at a compounded annual growth rate (CAGR) of 20.1% during the forecast period, according to a new report by Grand View Research, Inc. The rising use of cannabinoid-based products and increasing awareness regarding their health benefits are the major factors boosting the growth of the market. U.S. Minor Cannabinoids Market Segmentation Grand View Research has segmented the U.S. minor cannabinoids market based on product and application: Based on the Product Insights, the market is segmented into Cannabigerol (CBG), Cannabichromene (CBC), Cannabinol (CBN), Tetrahydrocannabivarin (THCV), Cannabigerolic acid (CBGA), Others (Cannabidiolic acid (CBDA), Cannabidivarin (CBDV), and other minor cannabinoids). Based on product type, tetrahydrocannabivarin (THCV) dominated the market with a revenue share of 24.8% in 2020. This high share is attributable...